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Psychosis has been proposed to develop from dysfunction 
in a hippocampal-striatal-midbrain circuit, leading to aber-
rant salience processing. Here, we used functional magnetic 
resonance imaging (fMRI) during novelty salience proc-
essing to investigate this model in people at clinical high risk 
(CHR) for psychosis according to their subsequent clinical 
outcomes. Seventy-six CHR participants as defined using 
the Comprehensive Assessment of At-Risk Mental States 
(CAARMS) and 31 healthy controls (HC) were studied 
while performing a novelty salience fMRI task that en-
gaged an a priori hippocampal-striatal-midbrain circuit of 
interest. The CHR sample was then followed clinically for 
a mean of 59.7 months (~5 y), when clinical outcomes were 
assessed in terms of transition (CHR-T) or non-transition 
(CHR-NT) to psychosis (CAARMS criteria): during this 
period, 13 individuals (17%) developed a psychotic disorder 
(CHR-T) and 63 did not. Functional activation and effec-
tive connectivity within a hippocampal-striatal-midbrain 
circuit were compared between groups. In CHR individuals 
compared to HC, hippocampal response to novel stimuli 
was significantly attenuated (P  =  .041 family-wise error 
corrected). Dynamic Causal Modelling revealed that stim-
ulus novelty modulated effective connectivity from the hip-
pocampus to the striatum, and from the midbrain to the 
hippocampus, significantly more in CHR participants than 
in HC. Conversely, stimulus novelty modulated connectivity 
from the midbrain to the striatum significantly less in CHR 
participants than in HC, and less in CHR participants who 
subsequently developed psychosis than in CHR individuals 
who did not become psychotic. Our findings are consistent 
with preclinical evidence implicating hippocampal-striatal-
midbrain circuit dysfunction in altered salience processing 
and the onset of psychosis.
Key words:  psychosis/prodrome/fMRI/hippocampus/sal
ience/schizophrenia
Introduction
The inappropriate attribution of salience to what would 
normally be irrelevant or neutral stimuli is a robust fea-
ture of psychotic disorders and is linked to altered sub-
cortical dopaminergic signaling.1,2 While there are a 
number of animal models that attempt to describe the pa-
thology and development of psychosis (eg, chronic phen-
cyclidine models, prenatal immune activation models (for 
review, see ref.3), a particularly influential model proposes 
that psychosis develops when hippocampal dysfunction 
drives increased subcortical dopamine activity through 
descending projections to the striatum.4,5 Neuroimaging 
studies of reward salience suggest that salience proc-
essing and associated neural hippocampal-striatal-
midbrain responses are perturbed in both patients with 
psychosis6,7 and individuals at clinical high risk (CHR) 
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for psychosis,8–11 and that this is associated with positive 
symptoms.11 In this context, although novelty has been 
less investigated as a dimension of salience than reward in 
psychosis,12 preclinical evidence indicates that dopamin-
ergic neurons in the midbrain code the salience of unex-
pected stimuli and respond to novel stimuli.13,14 The first 
aim of the present study was to examine hippocampal-
striatum-midbrain circuit activation and effective con-
nectivity in CHR individuals. We assessed activation 
using functional magnetic resonance imaging (fMRI) in 
conjunction with a novelty salience paradigm based on 
a task that had previously elicited robust hippocampal-
striatal-midbrain responses,15 and employed Dynamic 
Casual Modeling (DCM)16 to assess effective connec-
tivity within this circuit.
While previous neuroimaging studies had reported 
altered activation and connectivity in a hippocampal-
striatal-midbrain circuit during reward salience proc-
essing in CHR individuals,8,11 the extent to which these 
findings are specific to the CHR subset who later develop 
psychosis has yet to be investigated. Our second aim was 
to address this issue by examining the relationship be-
tween activation and connectivity within this circuit and 
the subsequent onset of a psychotic disorder. We, there-
fore, followed up our CHR participants to determine 
their clinical outcome.
Our primary hypothesis was that during novelty sali-
ence processing, hippocampal-striatal-midbrain circuit 
activation would be attenuated6,7,11 in CHR individuals 
compared to healthy controls (HC). We also examined 
how pure novelty salience processing altered effective 
connectivity in this circuit. Our second prediction was 
that these alterations would be particularly evident in the 
CHR subgroup who subsequently developed psychosis.
Methods
Participants
A total of 116 participants were recruited into the study. 
Ethical approval was obtained from the National Health 
Service UK Research Ethics Committee, and all partici-
pants provided written informed consent.
CHR participants (n = 85) were recruited from 4 dif-
ferent clinical sites in England: OASIS (Outreach and 
Support in South London),17 part of the South London and 
Maudsley NHS Trust; CAMEO, part of the Cambridge 
and Peterborough NHS Trust; the West London Early 
Intervention Service; and the Coventry and Warwick 
Warwickshire Partnership NHS Trust. All participants 
underwent clinical assessments and MRI scanning at 
King’s College London (KCL) by 2 trained researchers 
(CS and BQ). CHR signs and symptoms for inclusion 
were assessed with the Comprehensive Assessment of 
At-Risk Mental States (CAARMS).18 Exclusion criteria 
were past/present diagnosis of psychotic disorders, past/
present/familiar history of neurological illness, substance 
abuse/dependence according to DSM-5 criteria19 or con-
traindication to scanning.
HC (n = 31) were recruited from the same geographical 
areas as CHR participants. None had a personal/familial 
history of psychiatric/neurological disorder or were 
using prescription medication as assessed via self-report. 
Additional exclusion criteria for all participants involved 
self-reporting illicit substance use in the week prior to 
scanning or alcohol use in the 24 hours prior to scanning.
Clinical Measures
On the day of the MRI scan, the following measures were 
collected at KCL by trained raters: psychopathology 
using the CAARMS,18 anxiety and depression symp-
toms using the Hamilton Anxiety and Depression Scales 
(HAM-A/HAM-D),20 Premorbid IQ was estimated with 
the National Adult Reading Test (NART).21 Handedness 
was assessed using the Annett Handedness Scale.22 
Participants provided information on tobacco (cigar-
ettes/day), alcohol (units/day), and cannabis use (0 = no 
use, 1 = experimental use, 2 = occasional use, 3 = mod-
erate use, 4 = severe use).
Novelty Salience Task
All participants underwent fMRI scanning on a 3T GE 
scanner at KCL using an event-related novelty salience 
task adapted from Bunzeck and Duzel.15 Participants 
completed three 6-minute runs of a visual oddball par-
adigm (figure 1A). In each of the 3 runs, there were 80 
standards (same picture in 73% of trials), 10 target odd-
balls (same picture in 9% of trials, requiring a button 
press at each presentation), 10 neutral oddballs (same 
picture in 9% of trials), and 10 novel oddballs (a unique 
picture in 9% of trials representing a “pure novel stim-
ulus” 15), yielding a total of 360 stimuli across the entire 
18-minute experiment (240 standards, 30 target oddballs, 
30 neutral oddballs, and 30 novel oddballs). All pictures 
depicted black-and-white outdoor scenes.
The target stimulus, used solely to assess engage-
ment with the task as in the original study15 (there was 
no measure of accuracy during novelty processing), was 
presented at the start of the experimental session for 4.5 
seconds. Participants were asked to press a button with 
their right index finger every time it appeared (30 pres-
entations in total). During the experiment, pictures were 
presented for 500 ms followed by a white fixation cross 
on a gray background with an inter-stimulus interval of 
2.7 seconds, jittered between −300 ms and +300 ms (uni-
formly distributed).
Clinical Follow-up
The entire CHR sample was followed up subsequent to 
scanning to determine clinical outcome (transition/non-
transition to psychosis). The mean interval between baseline 
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and follow-up assessments was 59.7 months (SD = 15.4 mo). 
Transition to psychosis was determined using CAARMS 
Psychosis Threshold criteria18 and confirmed with the 
Structured Clinical Interview for Diagnosis,19 administered 
by a psychiatrist trained in its use.
Image Acquisition and Preprocessing
See supplementary material for details on fMRI acquisi-
tion and preprocessing.
Statistics
Demographic, Clinical, and Behavioral Data. Analyses 
of demographic data were performed in SPSS 24 (http://
www-01.ibm.com/software/uk/analytics/spss/). The ef-
fect of group on these measures was examined using 
independent samples t-tests for parametric data and 
Chi-square tests for nonparametric data. To examine the 
relationship between fMRI activation and transition to 
psychosis, the CHR sample was divided into 2 groups at 
follow-up: a transition to psychosis group (CHR-T) and 
a non-transition to psychosis group (CHR-NT). Analysis 
of behavioral data were performed in SPSS 24 for reac-
tion time (RT), target recognition and error rates using 
separate 2-sample t-tests: HC vs CHR and CHR-NT vs 
CHR-T. Significant effects are reported at P < .05 with 
Bonferroni post hoc correction as appropriate (demo-
graphic data: age, sex, IQ, years of education, handed-
ness, tobacco, alcohol, cannabis, antipsychotics, and 
antidepressant use—P < .05/10 = P < .005; clinical data: 
CAARMS positive, negative, total, GAF, HAM-A, and 
HAM-D—P < .05/6  =  P < .008; behavior: targetness, 
errors, and RT—P < .05/3 = P < .017).
fMRI Data Analysis. Statistical analysis of the fMRI 
data was conducted using the general linear model in 
SPM12. Separate regressors of interest were specified for 
each trial type: Standard, Target, Neutral, and Novel. 
Realignment parameters (x, y, z, pitch, roll, yaw) were in-
cluded in all first-level models as covariates of no interest 
to account for variance associated with head movement. 
All regressors were convolved with a canonical hemo-
dynamic response function during the 500 ms in which 
trials were presented. One contrast image was generated 
for each participant to examine activation related to pure 
stimulus novelty by contrasting all novel oddball trials 
against neutral oddball trials15 and was then submitted to 
second-level analysis.
For between-group comparisons between HC and 
CHR participants, a 2-sample t-test was performed using 
the first-level novel > neutral contrast images, covarying 
for age. We used an initial cluster defining threshold of 
P < .001 uncorrected to then enforce a voxel-wise height 
threshold of family-wise error (FWE) P < .05 after small 
volume correction (SVC) for region-of-interest (ROI) 
analyses,23,24 using a pre-specified bilateral mask com-
prising the hippocampus, striatum, and midbrain. The 
striatum was chosen on the basis of its role in the ab-
errant salience hypothesis2 and previous fMRI studies 
documenting salience–related responses in this region.25 
The hippocampus was chosen based on preclinical evi-
dence for its central role in psychosis through the regula-
tion of dopamine signaling,4 and prior work indicating a 
relationship between aberrant hippocampal activity and 
the CHR state.26,27 The midbrain was chosen since novel 
stimuli are associated with fMRI activations in this region 
as shown by Bunzeck and Duzel’s study using this task 
in healthy volunteers.15 The ROI mask was built using 
the WFU_Pitckatlas toolbox and comprised predefined 
anatomical masks of the striatum (caudate, pallidum, 
putamen) and the hippocampus from the automated an-
atomical labeling atlas, and a 6-mm sphere around the 
midbrain (ventral tegmental area/substantia nigra, VTA/
SN) coordinates reported in the study with healthy volun-
teers15 (only right-sided as in Bunzeck & Duzel,15 xyz: 8, 
−20, −18; figure 1B).
To investigate the relationship between functional 
activation in response to novelty and transition to psy-
chosis, a 2-sample t-test was specified in SPM (CHR-NT 
Fig. 1. (A) Task paradigm. (B) Region-of-interest mask used for small volume correction on the fMRI analysis, including the 
hippocampus, striatum, and midbrain. L = left hemisphere; R = right hemisphere.
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vs CHR-T), adjusting for age. The same ROI mask and 
significance threshold as above were applied (PFWE < .05 
after SVC). Potential confounding effects of substance 
use (alcohol, tobacco, cannabis) and levels of anxiety/
depression (HAM-A/HAM-D) on the regions showing 
significant novelty-related group differences were exam-
ined with an additional ANCOVA in SPSS. Exploratory 
whole-brain voxel-wise analysis of fMRI data (com-
paring all CHR to HC subjects and CHR-NT to CHR-T 
subjects) is reported in the supplementary material.
Dynamic Casual Modeling
Volumes of Interest and Time-Series Extraction. Based 
on preclinical evidence4,5 and data from a previous study 
of the task in healthy volunteers,15 we used DCM12 in 
SPM12 to compute effective connectivity within a cir-
cuit comprising the hippocampus, the striatum and the 
midbrain (figure 3A). The volumes of interest (VOIs) for 
these regions were defined using the maximally activated 
coordinates in the second-level fMRI analysis within our 
masked regions (figure 1B), following published rules for 
the application of DCM.28 The VOI for the hippocampus 
was extracted from the group-level fMRI difference be-
tween CHR vs HCs (xyz: 38 −16 −14). As there was no 
significant group-level difference in either the striatum 
or midbrain, we used the coordinates of the task effect 
of novel > neutral across all participants with an 8-mm 
sphere for each region, allowing the center of the sphere 
to move to the nearest suprathreshold voxel (xyz: stri-
atum, 28 20 −2; VTA/SN, 14 −24 −16; PUNC < .05).
Group Comparisons With Parametric Empirical Bayes 
(PEB). PEB, included in SPM12, allows evaluating 
group effects and between-subjects variability on DCM 
parameters (HC vs CHR; CHR-NT vs CHR-T). PEB for 
DCM is performed by comparing the posterior density 
of any (reduced) model in terms of the posterior of its 
parent or full model. The first step is to estimate a full 
model (ie, with every connection switched “on”) for every 
subject. Then, a nested model is constructed (ie, with cer-
tain conditions switched “off”), which allows the expres-
sion of the posterior density of any (reduced) model in 
terms of the posterior of its parent or full model. This 
process affords an efficient way to evaluate posterior 
densities under empirical priors. It is then possible to 
apply Bayesian model reduction to the posterior densities 
over the second-level parameters to find out where 
between-subject effects are expressed.29 Results are given 
by the group effect on the Posterior Probabilities (P) and 
the Bayesian Confidence Interval. Group differences were 
thresholded with a P > .5 obtained as recommended by 
DCM’s developers (https://arxiv.org/pdf/1902.10604.pdf) 
and following Kass & Raftery.30 Although comparing 
Bayes Factor to P-values is not straightforward, it could 
be argued that it is equivalent to P < 0.05.31 The present 
study examined how the connections between the ante-
rior hippocampus, ventral striatum and VTA/SN were 
modulated by stimulus novelty (novel > neutral oddball 
trials) by generating a second model space which included 
a full model, to then create 4 different models with each 
connection switched “off” (nested models; figure  3A). 
Group differences were then verified by comparing the 
evidence between the full model and the nested model. 
Group variables were de-meaned before being entered in 
the PEB model, to account for the different sample sizes 
of our study groups. Age was included as a covariate on 
all PEB analyses.
Additional exploratory analyses within the CHR group 
and its subgroups according to transition status were 
conducted to examine potential associations between 
severity of positive prodromal symptoms and fMRI re-
sponse to novelty/DCM connectivity strengths (supple-
mentary eFigure 1).
Results
Demographic and Clinical Data
Nine CHR participants were excluded from the final ana-
lyses due to incomplete fMRI data (n = 3), or excessive 
movement (n = 6). The analyzed sample thus comprised 
76 CHR participants and 31 HCs. Detailed examination 
of potential movement confounds is reported in supple-
mentary eTable 1 and eFigure 2.
All of the CHR participants met the CAARMS 
Attenuated Psychotic Symptoms criteria.32 A  minority 
additionally fulfilled the BLIPS (n  =  5) or schizotypal 
personality disorder/familial risk criteria (n = 2). At the 
time of scanning, most (67/76; 88%) CHR participants 
were naïve to antipsychotic medication. The remainder 
were taking low doses of antipsychotics (<1.5 mg halo-
peridol equivalents per day). The majority of CHR par-
ticipants were also anti-depressant free at the time of 
scanning (48/76; 63%).
The HC and CHR groups did not differ significantly 
in gender, handedness, estimated IQ, years of education, 
alcohol, or cannabis use. However, the CHR group was 
younger and smoked more tobacco. As would be expected, 
they showed higher levels of anxiety and depressive symp-
toms (HAM-A/HAM-D scores) and had lower levels of 
overall functioning compared to HCs (GAF score; table 1).
Thirteen of the CHR participants (17%) developed a psy-
chotic disorder within the follow-up period of 59.7 months 
(CHR-T), while 63 participants did not (CHR-NT). There 
were no significant differences in demographic or clinical 
variables at baseline between these groups (table 1).
Behavioral Data
The groups did not differ in their engagement with the 
fMRI task (mean RT or recognition of target stimuli; 
supplementary eTable 2).
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fMRI Data
Effect of Task. Across groups, pure stimulus novelty was 
associated with activation in the anterior hippocampus, 
ventral striatum and midbrain bilaterally (PFWE < .05 
after SVC; table 2, figure 2A).
Group Differences: All CHRs vs HCs.. In CHR parti-
cipants, relative to HC, pure stimulus novelty (novel > 
neutral oddball trial) was associated with significantly 
less activation in the anterior portion of the right hip-
pocampus than in HCs (PFWE = .041; xyz = 38 −16 −14; 
Z = 3.42, Hedges’ g = 0.543; figures 2B and C). There were 
no areas where CHR participants showed greater activa-
tion than HC. These findings remained unchanged after 
adding sex as additional covariate of no interest in the 
analysis (HC > CHR: right hippocampus, PFWE =  .033; 
xyz = 38 −16 −14; Z = 3.49, Hedges’ g = 0.544; CHR > 
HC no suprathreshold voxels).
Because resting-state neuroimaging studies in CHR 
groups have reported increased hippocampal per-
fusion/metabolism,26,27,33,34 we tested whether the re-
duced activation of  the right anterior hippocampus 
in CHR relative to HC during pure stimulus novelty 
reflected an increased response to the neutral com-
parator stimuli that fMRI studies traditionally use.35 
This supplementary analysis involved the contrast of 
neutral oddballs vs standards, reflecting activation re-
lated to unexpected, as opposed to novel stimuli, and 
revealed an increased hippocampal response in CHR 
relative to HC at a lenient threshold (P = .004 uncor-
rected, xyz = 36 −24 −16; kE = 20; Z = 2.66; Hedges’ 
g = 0.186; figure 1).
Group Differences: Transition to Psychosis. There 
were no significant differences in activation between 
the CHR-T subgroup and either the CHR-NT sub-
group or HCs. However, as in the total CHR sample, 
a lower right anterior hippocampal response to novel 
> neutral stimuli was evident when CHR-NT were 
compared with HC (PFWE  =  .018; xyz  =  38  −16  −14; 
Z = 3.68, Hedges’ g = 0.626). These findings remained 
unchanged after additionally adjusting the analysis for 
sex (HC > CHR-NT: right hippocampus, PFWE = 0.013; 
xyz  =  38  −16  −14; Z  =  3.76, Hedges’ g  =  0.488; HC 
<> CHR-T or CHR-NT <> CHR-T: no suprathreshold 
voxels). Clinical follow-up information (transition/non-
transition) was not available for 6 of  the 76 CHR in-
dividuals; repeating the transition analysis with these 6 
individuals excluded from the CHR-NT group did not 
change the results (HC > CHR-NT: right hippocampus, 
PFWE  =  .019; xyz  =  38  −16  −14; Z  =  3.64, Hedges’ 
g = 0.621; HC <> CHR-T or CHR-NT <> CHR-T: no 
suprathreshold voxels).
Analysis of Potential Confounders. A secondary anal-
ysis assessed the potentially confounding effects of  sub-
stance use (alcohol, cigarettes, and cannabis) and levels 
of  anxiety/depression (HAM-A/HAM-D) on the group 
difference in right anterior hippocampus activation. The 
group effect remained significant (F1,80 = 5.486, P = .022, 
Hedges’ g  =  0.742; supplementaty eTable 3). We also 
examined whether antipsychotic medication could have 
affected the results by repeating the analysis after the 
9 CHR participants who were receiving antipsychotics 
Table 1. Demographic and Questionnaire Data
Measure HC (n = 31) CHR (n = 76) g or V P CHR-NT (n = 63) CHR-T (n = 13) g or V P
Age (y) 25.0 (4.1) 22.46 (3.6) 0.677 .003 22.7 (3.8) 21.9 (2.6) 0.220 .488
Gender (male/female) 15/16 42/34 0.063 .518 36/27 6/7 0.083 .468
NART IQ 104.9 (13.7) 103.5 (14.6) 0.097 .669 103.6 (15.6) 103.1 (8.2) 0.034 .878
Years of education 15.8 (3.5) 14.6 (2.2) 0.455 .071 14.6 (2.2) 14.5 (2.5) 0.044 .907
CAARMS
 Positive score - 10.1 (4.1) -  9.7 (3.9) 11.8 (4.7) 0.520 .102
 Negative score - 5.1 (4.1) -  5.1 (4.1) 4.8 (4.3) 0.073 .785
 Total score - 42.3 (22.4) -  42.1 (21.9) 43.2 (25.5) 0.050 .873
GAF score 92.9 (5.0) 58.0 (9.5) 4.124 <.001 58.5 (9.7) 55.3 (8.5) 0.336 .272
HAM-A score 3.4 (4.2) 18.4 (11.2) 1.542 <.001 17.5 (10.4) 22.8 (14.2) 0.477 .173
HAM-D score 1.7 (3.5) 17.6 (11.1) 1.662 <.001 17.0 (11.1) 20.3 (11.2) 0.297 .396
Tobacco (cigarettes/d) 1.9 (3.4) 6.3 (9.0) 0.563 .001 7.2 (9.6) 2.1 (3.6) 0.573 .074
Alcohol (units/d) 1.7 (2.2) 1.6 (3.4) 0.032 .964 1.8 (3.6) 0.9 (0.7) 0.272 .426
Cannabis (median [range])a 0 [0–3] 0 [0–4] 0.146 .703 0 [0–4] 0 [0–4] 0.147 .811
Antipsychotic medication (n) - 9 (12%) - - 8 (13%) 1 (8%) 0.058 .611
Antidepressant medication (n) 1 (3.2%) 28 (37%) 0.343 <.001 25 (40%) 3 (23%) 0.130 .258
Right-handed (n) 26 (90%) 64 (85%) 0.187 .162 52 (83%) 12 (92%) 0.090 .434
Note: CAARMS, Comprehensive Assessment for the At-Risk Mental State; CHR, clinical high-risk; CHR-NT, clinical high-risk non-
transition; CHR-T, clinical high-risk transition; GAF, Global Assessment of Functioning scale; HAM-A, Hamilton Anxiety Rating 
Scale; HAM-D, Hamilton Depression Rating Scale; HC, healthy controls; NART, National Adult Reading Test. g or V, Hedges’ g or 
Cramer’s V. Statistically significant results (after correction as described in the Statistics section) are shown in bold text.
a0 = never, 1 = experimental use, 2 = occasional use, 3 = moderate use, 4 = severe use.
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Fig. 2. (A) Novel > Neutral oddball trials across groups and (B) Between-group clinical high-risk (CHR) vs healthy control (HC) 
results in right hippocampus for the contrasts of novel > neutral oddballs with activation superimposed on a standard T1 template. (C) 
Boxplots show mean hippocampal activation in each group for novel > neutral (pure stimulus novelty) and neutral > standard (stimulus 
rareness/deviance). L = left hemisphere; R = right hemisphere.
Table 2. Random Effects Analysis for Novel Oddballs vs Neutral Oddballs Across and Within Groups in the Hippocampal-Striatal-
Midbrain Region-of-Interest
Brain area
MNI Coordinates
k T Z Voxel-Wise PFWE x y z
Across all participants (n = 107)        
 R anterior hippocampus 32 −12 −14 568 5.52 5.16 <0.001
 L hippocampus −26 −30 −6 560 4.77 4.53 0.001
 R midbrain 12 −24 −16 50 4.37 4.18 <0.001
 R ventral putamen 28 20 −2 963 5.91 5.47 <0.001
 R dorsal pallidum 18 4 6  4.25 4.07 0.008
 R ventral caudate 14 8 6  4.15 3.98 0.012
 L ventral putamen −26 14 −4 540 4.28 4.10 0.008
HC (n = 31)        
 R anterior hippocampus 32 −14 −14 542 4.89 4.62 <0.001
 L hippocampus −22 −34 −6 552 3.96 3.82 0.011
 R midbrain 14 −18 −14 5 3.22 3.13 0.014
 R ventral putamen 32 4 −8 42 3.77 3.64 0.019
CHR (n = 76)        
 R hippocampus 22 −32 −2 18 3.63 3.51 0.031
 R midbrain 12 −24 −16 24 4.00 3.85 0.002
 R ventral putamen 28 20 −2 247 5.57 5.20 <0.001
 L ventral putamen −26 14 −6 19 3.68 3.56 0.024
CHR-NT (n = 63)        
 R midbrain 12 −24 −16 17 3.59 3.48 0.005
 R ventral putamen 28 20 −2 124 5.43 5.08 <0.001
CHR-T (n = 13)        
No suprathreshold voxels        
Note: L, left; R, right. CHR, clinical high-risk; CHR-NT, clinical high-risk non-transition; CHR-T, clinical high-risk transition; HC, 
healthy controls.
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had been excluded from the SPM design. Again, the 
group difference in the right anterior hippocampus re-
mained significant (PFWE  =  .042; xyz  =  38, −18  −14; 
Z = 3.43, Hedges’ g = 0.591). Finally, comparing CHR 
participants with (n = 28) vs CHR participants without 
(n = 48) antidepressants showed no suprathreshold ef-
fects at PFWE < .05.
Exploratory whole-brain fMRI results (comparing all 
CHR with HC subjects and CHR-NT with CHR-NT 
subjects) are reported in the supplementary eTable 4 and 
eFigure 3.
Effective Connectivity: All CHRs vs HCs. For the com-
parison of HC vs CHR groups, PEB revealed group 
differences in the modulatory effect of pure stimulus nov-
elty on hippocampal-striatal-midbrain connections. The 
CHR group showed relatively reduced connectivity from 
VTA/SN to striatum (P =  .52), but greater connectivity 
from hippocampus to striatum (P = .64) and from VTA/
SN to hippocampus (P = .68; figure 3B). These findings 
remained largely unchanged after additionally adjusting 
the analysis for sex (VTA/SN to hippocampus P =  .74; 
hippocampus to striatum P = .63; although VTA/SN to 
striatum P = .47).
Effective Connectivity: Transition to 
Psychosis. Comparison of  the CHR participants who 
subsequently developed psychosis and those who did 
not by PEB analysis also revealed a group difference: 
the CHR-T subgroup showed reduced connectivity 
from VTA/SN to striatum compared to the CHR-NT 
subgroup (P  = .51; figure  3C). This finding remained 
unchanged after additionally adjusting the analysis for 
sex (P  = .53). Repeating this analysis excluding the 6 
individuals for which follow-up clinical information 
was not available revealed that the reduced connectivity 
in CHR-T individuals from VTA/SN to striatum re-
mained significant (P = .71), and a further connectivity 
decrease was observed for the backward connection 
from the striatum to the VTA/SN (P = .75; supplemen-
tary eFigure 4).
Discussion
Our first major finding was that participants at CHR 
for psychosis showed an altered anterior hippocampal 
response during pure stimulus novelty processing, sug-
gesting that salience dysregulation is not only present 
in patients with psychosis, but is also evident before its 
onset. The result was not attributable to effects of age, 
treatment with antipsychotic or antidepressant med-
ication, substance use, anxiety/depression symptoms, 
or differential behavioral engagement with the fMRI 
task. Complementary whole-brain analysis showed no 
significant between-group differences (as shown in the 
supplementary material), suggesting that during “pure 
stimulus novelty” processing, regions outside our a priori 
hippocampal-striatal-midbrain mask would not be differ-
entially engaged by CHR individuals. The second major 
finding came from applying a circuit-based approach to 
examine functional coupling within a hippocampus–stri-
atal–midbrain circuit during salience processing. CHR 
subjects showed significantly reduced effective connec-
tivity from the midbrain to the striatum compared to 
controls, but greater connectivity from the hippocampus 
to the striatum and from the midbrain to the hippo-
campus. The reduction in midbrain-striatal connectivity 
in the whole sample was also evident in the subgroup who 
later became psychotic compared to the subgroup who 
did not. Overall, the results support previous reports that 
altered salience-related response in the hippocampus is 
associated with psychosis risk,8,11 and suggest that the 
subsequent development of psychosis may rather be 
based on circuit-based connectivity disruptions.
According to a well-validated neurodevelopmental an-
imal model, the methylazoxymethanol acetate (MAM) 
model, increased tonic activity of the ventral/anterior 
hippocampus leads the ventral striatum to disinhibit the 
midbrain via inhibition of the ventral pallidum, which 
increases the number of spontaneously active midbrain 
dopamine neurons.4,36 Human imaging evidence has been 
largely consistent with this model.37 Resting cerebral 
blood volume (CBV) or flow (CBF) is elevated in the an-
terior hippocampus of patients with schizophrenia33,34,38,39 
Fig. 3. (A) DCM model. (B) Group effects on PEB models between HC and CHR. (C) Group effects on PEB models between CHR-NT 
and CHR-T. Gray bars show posterior probabilities for model evidence. Bars represent the Bayesian 95% confidence interval.
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and CHR individuals.26,27,34 Higher levels of CBV/CBF 
are positively associated with psychotic symptoms in 
CHR subjects33 and with subclinical psychotic-like ex-
periences in schizotypal individuals.40 Furthermore, CHR 
subjects show elevated striatal dopamine function,41,42 an 
association between striatal dopamine function and re-
duced hippocampal activation during a memory task,43 
and altered hippocampal glutamate levels.44,45 In turn, al-
tered hippocampal glutamate levels have been related to 
abnormal hippocampal activation during a memory task 
in CHR.46 Our findings extend this literature by showing 
that hippocampal dysregulation is also evident when 
CHR individuals process novelty salience.
An important consideration in the interpretation of 
fMRI data is that increases and decreases in BOLD re-
sponse depend on (1) the direction of the change in re-
gional brain activity relative to the baseline for both 
the control and the task condition, (2) the way in which 
the control condition and the condition of interest are 
compared, and (3) comparing groups which may have 
different baseline states.35,47 Our novelty salience para-
digm was adapted from that employed by Bunzeck and 
Duzel,15 showing that the VTA/SN preferentially re-
sponds to stimulus novelty over other forms of stimulus 
salience. The contrast between novel and neutral odd-
balls allowed quantification of neural response to what 
the authors called “pure stimulus novelty,” as opposed to 
rareness/deviance per se.15 Our results suggest that the re-
duced response to pure stimulus novelty in the right ante-
rior hippocampus in CHR individuals may be driven by 
increased response to the control condition comprising 
neutral stimuli (albeit at an uncorrected level).
In terms of effective connectivity within this circuit, 
relative to controls, CHR subjects showed greater mod-
ulation by pure stimulus novelty in the connection from 
hippocampus to striatum and from midbrain to hippo-
campus. While this analysis also indicated reduced modu-
lation of connectivity from midbrain to striatum in CHR 
individuals, this effect was no longer significant once 
sex was adjusted for in the analysis, suggesting a poten-
tial relationship between midbrain-striatal connectivity 
and sex in the CHR state which merits further research. 
Overall, these findings suggest that, in CHR subjects, af-
ferent and efferent connectivity of the hippocampus were 
increased, consistent with disrupted interactions within 
a hippocampal-striatal-midbrain circuit being associ-
ated with increased risk for psychosis. This pattern of 
dysconnectivity would be in line with the maximal tonic 
activation of dopamine neuron firing hypothesized to 
occur in psychosis, thought to obscure salience-driven in-
creases in population activity of mesostriatal dopamine 
neurons,36 leading to all stimuli being inappropriately 
registered as salient. This could account for the increased 
response to non-novel stimuli, and the attenuation of the 
hippocampal response to salient stimuli, observed in the 
CHR group.
Although the later onset of psychosis in CHR 
subjects was not associated with significant differences in 
hippocampal activation, this subgroup showed reduced 
modulation by pure stimulus novelty of the effective con-
nectivity from midbrain to striatum compared to CHR 
subjects who did not become psychotic. As a similar al-
teration in midbrain-striatal connectivity was also evi-
dent in the total CHR sample relative to controls (above), 
this suggests that among the changes in connectivity seen 
in the CHR sample, alterations in communication from 
midbrain to striatum may be particularly relevant to the 
subsequent onset of psychosis. This would be consistent 
with PET studies in CHR subjects showing elevated mid-
brain and striatal dopamine function linked to later tran-
sition to psychosis.42,43 An alternative explanation relates 
to a “ceiling effect” for hippocampal activity and subcor-
tical connectivity in dopamine-related regions; the lower 
hippocampal response to novel vs non-novel stimuli could 
reflect a reduced signal-to-noise ratio in the comparison 
between these 2 conditions in CHR individuals, sup-
ported by the (uncorrected) hyper-responsivity to the neu-
tral comparator condition. This notion is consistent with 
previous findings on emotional salience in CHR groups 
that lower responses to emotional stimuli are driven by 
increased responses to the neutral, nonemotional condi-
tion,48–52 and by reports of increased resting hippocampal 
perfusion in CHR.26,27,33,34 Taken together, these results 
suggest that increased baseline activity/tonic dopamine 
signaling within this circuitry may render CHR/CHR-T 
individuals less able to “effectively” distinguish between 
novel (salient) and non-novel (non-salient) stimuli.
Despite studying a relatively large sample of CHR subjects, 
the number in the CHR-T subgroup was small; the findings in 
this subgroup should, therefore, be interpreted with caution, 
and warrant replication in larger samples. Previous imaging 
studies of salience processing in CHR individuals relative to 
HCs have found significant differences in activation of the 
hippocampal-striatal-midbrain circuit in the context of re-
ward/motivational salience,8,11 but not novelty or emotional 
salience. A possible explanation for this discrepancy might 
relate to modest sample sizes in previous studies, as we in-
cluded a relatively large CHR sample (n = 76). Additional 
sources for discrepancies might relate to the use of different 
salience task paradigms, tapping on different dimensions of 
salience processing. More specifically, Roiser et al11 used the 
Salience Attribution Task (SAT), a monetary reward task 
measuring adaptive and aberrant motivational salience. In 
contrast, Winton-Brown et al8 used the Salience Integration 
Task (SIT), a monetary incentive delay task in which condi-
tions were manipulated to examine reward (monetary), nov-
elty (with half of the trials as pre-familiarized and the other 
half as novel), and aversion (with half of the pictures as 
emotionally aversive). Given that salience is a multifaceted 
construct,12 and that novelty salience had not been studied 
in relation to transition to psychosis, we used a task par-
adigm known to robustly isolate the specific processing of 
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novelty.15 In terms of findings, Roiser et al focused on the 
dorsolateral prefrontal cortex, hippocampus, and midbrain, 
and found that the magnitude of aberrant motivational sa-
lience attribution was positively correlated with ventral stri-
atal responses to non-salient cue features.11 Winton-Brown 
et al focused on the hippocampus, striatum, and midbrain, 
and found significant group differences with CHR subjects 
showing greater activation than HC to reward-predicting 
stimuli in the ventral pallidum and in the midbrain/hippo-
campus, while they did not observe any significant effects for 
novelty or emotional salience.8 In the present study, using a 
specific “pure stimulus novelty” salience task, we observed a 
significant difference in hippocampal responsivity between 
HC and CHR individuals. Finally, Roiser et al11 had shown 
an abnormal association between hippocampal response to 
motivational salience and dopamine synthesis capacity in a 
smaller sample of CHR individuals. Given that the hippo-
campus is central to the processing of novelty salience,53 it 
would be interesting to determine whether the hippocampal 
alteration we detected during novelty processing is also ab-
normally associated with dopamine synthesis capacity in 
CHR individuals.
In summary, the data from the present study in-
dicate both perturbed hippocampal activation and 
hippocampal-striatal-midbrain effective connectivity in 
the context of novelty salience in people at CHR for psy-
chosis, and that the later onset of psychosis is associated 
with alterations in midbrain-striatal connectivity. These 
findings are consistent with data from preclinical models 
of psychosis implicating alterations in a hippocampal–
striatal-midbrain circuit in the development of psychosis.
Supplementary Material
Supplementary material is available at Schizophrenia 
Bulletin online.
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